Literature DB >> 9546289

Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome?

P G Ince1, E K Perry, C M Morris.   

Abstract

Lewy body formation is central to the pathological phenotype of a spectrum of disorders. The most familiar of these is the extrapyramidal syndrome of idiopathic Lewy-body Parkinson's disease (PD). Studies of dementia in the elderly suggest that another manifestation of Lewy body pathology is equally or more common than Parkinson's disease. This syndrome of Dementia with Lewy bodies (DLB) has been given a number of diagnostic labels and is characterised by dementia, relatively mild parkinsonism, visual hallucinations, and fluctuations in conscious level. Although many of these features can arise in Parkinson's disease, the patients with DLB tend to have early neuropsychiatric features which predominate the clinical picture, and the diagnosis of the syndrome in practice is more concerned with the differential diagnosis of Alzheimer's disease (AD). Distinction from AD has clinical importance because of potentially differing therapeutic implications. Diagnostic guidelines for the clinical diagnosis and pathological evaluation of DLB are reviewed. Research into the disorder has centered around characterising the clinical, neuropsychological, pathological, neurochemical and genetic relationships with Alzheimer's disease on the one hand, and Parkinson's disease on the other. Many cases of DLB have prominent pathological features of AD and there are some shared genetic risk factors. Differences from the pathology of PD are predominantly quantitative rather than qualitative and evidence is discussed which suggests that DLB represents a clinicopathological syndrome within the spectrum of Lewy body disorders. The possibility that the syndrome represents a chance association of PD and AD is not supported by published studies.

Entities:  

Mesh:

Year:  1998        PMID: 9546289     DOI: 10.1111/j.1750-3639.1998.tb00156.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  11 in total

1.  Neuropathology in mice expressing human alpha-synuclein.

Authors:  H van der Putten; K H Wiederhold; A Probst; S Barbieri; C Mistl; S Danner; S Kauffmann; K Hofele; W P Spooren; M A Ruegg; S Lin; P Caroni; B Sommer; M Tolnay; G Bilbe
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Dementia with Lewy bodies: no association of polymorphisms in the human synphilin gene.

Authors:  J Busby; K K O'Brien; A M Gibson; I G McKeith; R H Perry; J A Hardy; A B Singleton; C M Morris
Journal:  Neurogenetics       Date:  2004-12       Impact factor: 2.660

3.  Mills syndrome with dementia: broadening the phenotype of FTD/MND.

Authors:  M Doran; T P Enevoldson; E J Ghadiali; A J Larner
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

Review 4.  The neuropsychological profile of Alzheimer disease.

Authors:  Sandra Weintraub; Alissa H Wicklund; David P Salmon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

5.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; M Hasegawa; M Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 6.  Lewy Body Disease: Clinical and Pathological "Overlap Syndrome" Between Synucleinopathies (Parkinson Disease) and Tauopathies (Alzheimer Disease).

Authors:  Clovis Foguem; Patrick Manckoundia
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-08       Impact factor: 5.081

Review 7.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

8.  Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.

Authors:  J G Culvenor; C A McLean; S Cutt; B C Campbell; F Maher; P Jäkälä; T Hartmann; K Beyreuther; C L Masters; Q X Li
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 9.  Dementia with Lewy bodies - from scientific knowledge to clinical insights.

Authors:  Nikitas A Arnaoutoglou; John T O'Brien; Benjamin R Underwood
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

Review 10.  Dementia with Lewy bodies: disease concept and genetics.

Authors:  Manuel B Graeber; Ulrich Müller
Journal:  Neurogenetics       Date:  2003-07-26       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.